Section ofEndocrinology 647 Serum HGH concentrations in pregnancy and in the post-partum period have not previously been recorded. Our findings indicate that the concentration is normal during pregnancy but increased in the post-partum period. This is of special interest because of the known requirement for growth hormone in mammary gland development and in milk secretion (Lyons et al. 1955 ) but more particularly because it is known that the administration of growth hormone to animals in declining lactation leads to a resurgence of milk production (Cotes et al. 1949) .
The Immunological Assay of Growth Hormone [Abstract] by M Hartog BM MRCP and Russell Fraser MD FRCP (London)
The paper described the technique, its accuracy and the results obtained in 18 normal subjects, 11 patients with acromegaly and 7 hypophysectomized patients. This work has recently been published (J. Endocrin. 22, 101) .
In addition results in 5 patients with active acromegaly who had been treated by pituitary implantation were presented. Two of these patients experienced no improvement following implantation of 198Au and their serum GH values were unchanged. Another patient whose serum GH was also unchanged experienced some improvement following 198Au. Two patients had clear clinical improvement, one following 198Au and the other following 90Y implantation, and their serum GH values fell significantly from their pre-implant figures.
Immunological Study of Human Gonadotrophins by W R Butt PhD ARIC, A C Crooke MD MRCP and F J Cunningham BSC (Birmingham)
There is an extensive literature on the early work on antibodies or antihormones to gonadotrophins which has been fully reviewed by Zondek & Sulman (1942) and by Evans & Simpson (1950) . Interest in the subject has been renewed by the preparation of -purer hormones and by more recent developments in immunological techniques (Henry & van Dyke 1958) . Recently Wide & Gemzell (1960) and Brody & Carlstr6m (1960 , 1961 have claimed to have developed immunological assays for chorionic gonadotrophin as a test for pregnancy. We have been interested in cross-reactions between different gonadotrophic antigens and antisera which suggest that they may be unspecific (Butt et al. 1960) .
Antisera have been raised against gonadotrophins from the urine of both postmenopausal (HMG, human menopausal gonadotrophin) and pregnant women (HCG, human chorionic gonadotrophin) and also from human pituitary glands (HPG). The extracts from the urine of postmenopausal women have been purified using ion exchange materials by methods described previously (Butt et al. 1959) and HCG was supplied by Leo Pharmaceutical Products Ltd (Copenhagen). Human pituitary preparations supplied by Dr A Korner of the Department of Biochemistry, Cambridge University, were fractionated on columns of carboxymethyl (CM) cellulose and diethyl aminoethyl (DEAE) cellulose and calcium phosphate (CP) (Butt, Crooke & Cunningham, in press). The antigens were dissolved in saline and mixed with an equal weight of bentonite to which they adsorb strongly. 2-0 ml of the suspension, usually containing 0 5 mg protein were given intravenously to rabbits twice a week for three or more weeks. Biologically active antisera have been obtained against HMG, HPG and HCG using the following amounts of protein:
(1) HMG 20 mg of the DEAE fraction having a total potency equivalent to 300 mg of the International Reference substance, HMG24.
(2) HPG 5 mg of the DEAE fraction having a total potency equivalent to 1,300 mg HMG24
(3) HCG 2*75 mg having a total potency equivalent to 4,400 i.u. The activity of the antisera was tested in vivo using mice or rats. Each serum was injected intraperitoneally and the next day the antigen was given subcutaneously. Antisera to both HMG and
